Dasabuvir is a ROCK1 inhibitor that can block the ROCK1/ERK signaling pathway, consequently downregulate the expression of CDK4 and cyclin D1, thus arresting ESCC cells in the G0/G1 phase. This evidence concerns the gene CDK4 and esophageal squamous cell carcinoma.